Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-
Source: eagletribune.com
Stay updated with breaking news from Simple Endoscopic Activity Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-Enrollment continued on target in EMERALD-2 Phase 2b trial of MORF-057 in ulcerative colitis-